CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma

CKLF‐like MARVEL transmembrane domain containing 6 (CMTM6) was identified as a regulator of programmed death ligand 1 (PD‐L1), which induces antitumor immunity in several cancers. This study aimed to clarify the relationship between CMTM6 and PD‐L1 expression and clinical outcomes in patients with h...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hepatol Commun
Päätekijät: Yugawa, Kyohei, Itoh, Shinji, Yoshizumi, Tomoharu, Iseda, Norifumi, Tomiyama, Takahiro, Morinaga, Akinari, Toshima, Takeo, Harada, Noboru, Kohashi, Kenichi, Oda, Yoshinao, Mori, Masaki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7850307/
https://ncbi.nlm.nih.gov/pubmed/33553979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1643
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia